Drug Price Trends for COUGH-COLD HBP TABLET

Average Pharmacy Cost for COUGH-COLD HBP TABLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
COUGH-COLD HBP TABLET	70000-0324-01	0.10119	EACH	2024-12-18
COUGH-COLD HBP TABLET	70000-0324-01	0.10392	EACH	2024-11-20
COUGH-COLD HBP TABLET	70000-0324-01	0.10319	EACH	2024-10-23

Market Analysis and Price Projections for Coricidin HBP Cough & Cold Tablets

Market Overview

The global cough and cold preparations market is experiencing significant growth, driven by various factors such as the increased prevalence of respiratory diseases, global warming, and rising healthcare expenditure. By 2028, the market is projected to reach $104.31 billion, growing at a compound annual growth rate (CAGR) of 5.1%[3].

Segment Analysis

Coricidin HBP Cough & Cold Tablets fall under the category of upper respiratory combinations, specifically targeting individuals with high blood pressure. Here are some key segments relevant to this product:

By Drug Type

• The market is segmented by drug type, including antihistamines, expectorants, bronchodilators, and decongestants. Coricidin HBP Cough & Cold Tablets contain chlorpheniramine maleate (an antihistamine) and dextromethorphan hydrobromide (a cough suppressant)[5].

By Dosage Type

• The product is available in tablet form, which is one of the common dosage types in the market, along with oral syrups, nasal drops, and lozenges[3].

By Distribution Channel

• These tablets are widely available through retail pharmacies, drug stores, and can also be found behind the pharmacy or customer service counter at local retailers[1][5].

Regional Market

Global Market Share

• North America was the largest region in the cold and cough preparation market in 2023. However, the Middle East is expected to be the fastest-growing region during the forecast period[3].

Regional Growth

• The growth in different regions is influenced by factors such as economic growth, healthcare expenditure, and government initiatives. For instance, the Middle East is anticipated to see significant growth due to these factors[3].

Price Analysis

Current Pricing

• The cost for Coricidin HBP Cough & Cold Tablets (4 mg-30 mg) is approximately $15 for a supply of 16 tablets, depending on the pharmacy. This price is for cash-paying customers and does not include insurance plans[2].

Discounts and Assistance Programs

• There are discount cards available, such as the Drugs.com Discount Card, which can save consumers up to 80% off the cost of the medication. However, no patient assistance programs or manufacturer promotions were found specifically for Coricidin HBP Cough & Cold Tablets[2].

Price Projections

Given the overall growth of the cough and cold preparations market, here are some projections for Coricidin HBP Cough & Cold Tablets:

Market Growth Impact

• As the market grows, the demand for decongestant-free cough and cold medicines, especially those suitable for individuals with high blood pressure, is likely to increase. This could lead to stable or slightly increasing prices due to higher demand[3].

Economic Factors

• High inflation and global economic events, such as the Ukraine-Russia war, can impact the pricing of pharmaceuticals. However, these factors are generally more influential on raw material costs and manufacturing rather than the final consumer price of established products like Coricidin HBP Cough & Cold Tablets[3].

Competitive Landscape

• The market is competitive, with various brands offering similar products. This competition can help keep prices relatively stable, as companies aim to maintain market share without significantly increasing prices[3].

Potential Risks and Considerations

Abuse and Misuse

• There is a notable risk of abuse and misuse of Coricidin HBP Cough & Cold Tablets, particularly among teenagers. This could lead to regulatory scrutiny and potential changes in how the product is marketed or distributed[4].

Regulatory Environment

• Regulatory changes, such as those imposed by the FDA, can impact the market. For example, restrictions on the use of certain ingredients can affect product formulations and pricing[3].

Key Takeaways

• Market Growth: The global cough and cold preparations market is expected to grow significantly, driven by increased prevalence of respiratory diseases and other factors.
• Segment Analysis: Coricidin HBP Cough & Cold Tablets are part of the upper respiratory combinations segment, targeting individuals with high blood pressure.
• Price Stability: Prices for Coricidin HBP Cough & Cold Tablets are likely to remain stable or see slight increases due to market growth and demand.
• Regulatory and Social Factors: The product is subject to regulatory scrutiny and social concerns such as abuse and misuse.

FAQs

1. What are the active ingredients in Coricidin HBP Cough & Cold Tablets?

• The active ingredients are chlorpheniramine maleate (an antihistamine) and dextromethorphan hydrobromide (a cough suppressant)[5].

2. Why are Coricidin HBP Cough & Cold Tablets decongestant-free?

• These tablets are decongestant-free to make them suitable for individuals with high blood pressure, as decongestants can elevate blood pressure[1].

3. What is the current price range for Coricidin HBP Cough & Cold Tablets?

• The cost is approximately $15 for a supply of 16 tablets, depending on the pharmacy[2].

4. Are there any discount programs available for Coricidin HBP Cough & Cold Tablets?

• Yes, discount cards like the Drugs.com Discount Card can save consumers up to 80% off the cost of the medication[2].

5. What are the potential risks associated with Coricidin HBP Cough & Cold Tablets?

• There is a high rate of abuse among teenagers, and the product can cause various side effects such as tachycardia, hypertension, and altered mental status if misused[4].

Sources

1. Coricidin® HBP Cough & Cold - Coricidin® HBP
2. Coricidin HBP Cough & Cold Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com
3. Cough And Cold Preparations Global Market Report 2024 - The Business Research Company
4. Abuse of Coricidin HBP cough & cold tablets - PubMed
5. Coricidin Hbp Cough & Cold Tablets, 16-count - Navy Exchange